100 related articles for article (PubMed ID: 16466103)
1. Pulsed immunosuppression with everolimus and anti-alphabeta T-cell receptor: laryngeal allograft preservation at six months.
Khariwala SS; Knott PD; Dan O; Klimczak A; Siemionow M; Strome M
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):74-80. PubMed ID: 16466103
[TBL] [Abstract][Full Text] [Related]
2. Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression.
Lott DG; Russell JO; Khariwala SS; Dan O; Strome M
Ann Otol Rhinol Laryngol; 2011 Feb; 120(2):131-6. PubMed ID: 21391426
[TBL] [Abstract][Full Text] [Related]
3. Donor bone marrow in laryngeal transplantation: results of a rat study.
Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M
Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835
[TBL] [Abstract][Full Text] [Related]
4. Induction with T-cell receptor antibody leads to long-term laryngeal allograft function.
Knott PD; Dan O; Strome M
Am J Otolaryngol; 2008; 29(6):398-402. PubMed ID: 19144301
[TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance in a rat model of laryngeal transplantation.
Akst LM; Siemionow M; Dan O; Izycki D; Strome M
Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
[TBL] [Abstract][Full Text] [Related]
6. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
7. Long-term laryngeal allograft survival using low-dose everolimus.
Lott DG; Dan O; Lu L; Strome M
Otolaryngol Head Neck Surg; 2010 Jan; 142(1):72-8. PubMed ID: 20096226
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
9. Laryngeal transplantation in the setting of cancer: a rat model.
Shipchandler TZ; Lorenz RR; Lee WT; Teker AM; Dan O; Strome M
Laryngoscope; 2008 Dec; 118(12):2166-71. PubMed ID: 18948827
[TBL] [Abstract][Full Text] [Related]
10. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
11. Effect of in vitro irradiation of donor larynges on cyclosporine requirements and rejection rates in rat laryngeal transplantation.
Barthel SW; Dan O; Myles J; Strome M
Ann Otol Rhinol Laryngol; 2001 Jan; 110(1):20-4. PubMed ID: 11201803
[TBL] [Abstract][Full Text] [Related]
12. Suppression of allograft rejection with anti-alphabeta T cell receptor antibody in rat corneal transplantation.
Yamagami S; Tsuru T; Ohkawa T; Endo H; Isobe M
Transplantation; 1999 Feb; 67(4):600-4. PubMed ID: 10071034
[TBL] [Abstract][Full Text] [Related]
13. The effect of donor-specific transfusion upon rejection in a rat model of laryngeal transplantation.
Akst LM; Dan O; Strome M
Am J Otolaryngol; 2006; 27(1):13-7. PubMed ID: 16360817
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Effects of Different Cellular Therapies of Bone Marrow Origin on Chimerism Induction and Maintenance Across MHC Barriers in a Face Allotransplantation Model.
Hivelin M; Klimczak A; Cwykiel J; Sonmez E; Nasir S; Gatherwright J; Siemionow M
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):299-310. PubMed ID: 26708158
[TBL] [Abstract][Full Text] [Related]
15. Anti-αβ-T-cell receptor antibodies in the setting of laryngeal transplantation.
Strome M; Lott DG
Immunotherapy; 2010 Nov; 2(6):835-45. PubMed ID: 21091115
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
Scharpf J; Strome M; Siemionow M
Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
[TBL] [Abstract][Full Text] [Related]
17. Strategies to develop chimerism in vascularized skin allografts across MHC barrier.
Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ
Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunosuppressive therapy after experimental small bowel transplantation in rats.
Pech T; Fujishiro J; Finger T; von Websky M; Stoffels B; Wehner S; Abu-Elmagd K; Kalff JC; Schaefer N
Transpl Immunol; 2011 Sep; 25(2-3):112-8. PubMed ID: 21820512
[TBL] [Abstract][Full Text] [Related]
19. Suppression of bronchiolitis obliterans in allogeneic rat lung transplantation--effectiveness of everolimus.
von Suesskind-Schwendi M; Brunner E; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Exp Toxicol Pathol; 2013 May; 65(4):383-9. PubMed ID: 22284335
[TBL] [Abstract][Full Text] [Related]
20. Use of genetically modified allograft to deliver local immunomodulatory molecule with minimal systemic toxicity in a rat model of allogeneic skin flap transplantation.
Fu S; Yang Y; Xiao B; Li Y; Yi CG; Xia W; Guo SZ
Transplant Proc; 2010 Nov; 42(9):3815-9. PubMed ID: 21094862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]